Jumawan, Baby Girl .
HRN: 26-69-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/27/2025
CEFOTAXIME 500MG (VIAL)
02/27/2025
03/06/2025
IV
135mg
Q8H
Neonatal Sepsis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes